10 chief scientific officers

Experience: EVP & Chief Scientific Officer · Perrigo Company plc

EVP & Chief Scientific Officer at Perrigo Company plc since 2025. Her profile says she serves on Perrigo's Executive Leadership Team and leads the global Scientific Office, which brings together Regulatory Affairs and other functions. She was formerly EVP & Executive Committee Member, Trust & Science Head, Bayer Consumer Health at Bayer (2019–2024) and Head of Regulatory Affairs Bayer Consumer Healthcare (2019–2020).

Experience: Chief Scientific Officer · Moderna

Chief Scientific Officer at Moderna since 2021, a C-level research role. His other listed Moderna roles are VP and Head of Research, Infectious Disease (2018–2021) and Project Leader and Senior Director, Antigen Design and Selection (2017–2018). He was also Head, Protein Biochemistry and Discovery Project Leader at GSK (2015–2016) and Global Head, Structural Biology at Novartis (2013–2015).

Experience: Chief Scientific Officer, Executive Vice President, Novonesis · Novonesis

Chief Scientific Officer, Executive Vice President, Novonesis at Novonesis since 2024, and former Chief Science Officer, Executive Vice President at Novozymes (2020–2024). His other listed Novozymes roles include senior vice president, Research & Technology (2016–2020), Vice President (2014–2016) and Managing Director (2010–2012).

Experience: Executive Vice President and Chief Scientific Officer · Eli Lilly and Company

Former Executive Vice President and Chief Scientific Officer at Eli Lilly and Company (2018–2025) and Executive Vice President and Chief Scientific and Product Officer there since 2025. His profile says he leads teams that turn scientific ideas into medicines, serves as president of Lilly Research Laboratories and oversees Lilly's global business development efforts. He was also Founder and Chief Executive Officer of Avid Radiopharmaceuticals, Inc. (2005–2012).

Experience: Chief Scientific Officer · Calico Life Sciences

Chief Scientific Officer at Calico Life Sciences since 2014, a C-level research role listed as current. He was formerly Professor and Director, Lewis-Sigler Institute at Princeton University (2003–2013) and Chairman, Department of Genetics at Stanford University School of Medicine (1990–2003).

Experience: Chief Scientific Officer · Ionis Pharmaceuticals, Inc.

Chief Scientific Officer at Ionis Pharmaceuticals, Inc. since 2020; his other listed Ionis roles include Senior Vice President, Research (2006–2020) and Vice President, Antisense Research (1999–2006). His profile describes him as executive vice president and chief scientific officer and one of the founding members of the company, responsible for advancing antisense technology and expanding the Ionis drug discovery platform.

Experience: Chief Scientific Officer and Senior Vice President of Bruker Spatial Biology · Bruker Spatial Biology

Chief Scientific Officer and Senior Vice President of Bruker Spatial Biology since 2024. His profile also lists Chief Scientific Officer and SVP of Research and Development at NanoString Technologies, Inc. from 2020 with no end date, and Senior Vice President of Research and Development at NanoString (2012–2020). He was formerly Chief Technology Officer at Life Technologies (2007–2012).

Experience: Chief Scientific Officer · Alnylam Pharmaceuticals

Chief Scientific Officer at Alnylam Pharmaceuticals since 2018, after serving as Head of Research there from 2005 to 2018. His profile says he was promoted through Director, Senior Director, Vice President and SVP to CSO and currently leads a research department of more than 100. He was also a Group Leader at Bristol Myers Squibb (1998–2005).

Experience: Chief Scientific Officer and Global Head of Research · Sanofi

Chief Scientific Officer and Global Head of Research at Sanofi since 2024, a C-level role in the research department. He was formerly Co-Founder, President and Chief Executive Officer of Dualitas Therapeutics (2023–2024), President & Chief Executive Officer of Therini Bio, Inc. (2021–2023) and Venture Partner at SV Health Investors (2021–2024), and has been a Scientific Advisory Board Member at Enara Bio since 2020.

Experience: Chief Scientific Officer · Genesis Molecular AI

Chief Scientific Officer at Genesis Molecular AI since 2024; the profile describes Genesis Molecular AI as a biotechnology research company. He was formerly EVP and Head of Discovery at Odyssey Therapeutics (2021–2024), and his Novartis roles include Executive Director of Discovery Chemistry (2013–2021) and Associate Director of Medicinal Chemistry (2008–2013).